In OASIS 4, gastrointestinal effects affected around 74% of those on the Wegovy pill compared with 42% on placebo, led by nausea (roughly 47% vs 19%) and vomiting (about 31% vs 6%), with diarrhoea and constipation also common
The significant SOCs that met four criteria were injury, poisoning and procedural complications and gastrointestinal disorders
The high cost and growing demand for weight-loss medications like Wegovy (semaglutide) have led to increased interest in insurance coverage for the drug
Be active Incorporating regular exercise into your routine, whether youre using semaglutide or not, is key to overall health
Try to lose weight at a steady and healthy pace
Finally, the pathway has been associated with promoting islet cell proliferation and function, which is critical for maintaining glucose homeostasis 12